| ATCC BAA-1564| Blautia wexlerae| Blautia wexlerae Liu et al. 2008| DSM 19850| WAL 14507
Short-Chain Fatty Acid Production: Blautia species, like other members of the Lachnospiraceae family, are involved in the fermentation of dietary fibers and complex carbohydrates. This fermentation process produces short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate. SCFAs play a role in gut health, providing energy for colonocytes and contributing to the maintenance of gut barrier function.
Metabolic Health: The abundance and composition of Blautia species, including Blautia wexlerae, have been associated with metabolic conditions, including obesity and metabolic syndrome. However, the specific roles of individual species and their contributions to metabolic health are areas of ongoing research.
Gut Microbiota Composition: Blautia wexlerae, as a member of the Blautia genus, contributes to the overall composition of the gut microbiota. The gut microbiota is increasingly recognized as playing a crucial role in maintaining overall health, including immune function and metabolic balance.
Influence on Immune System: Some Blautia species have been studied for their potential influence on the host immune system. Interactions between gut bacteria, including Blautia wexlerae, and the immune system are complex and can impact immune responses and tolerance.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 3.93 | 0 | 0 | 1 | 118770 | 0 | 70667 | 21601.1 | 12050 | 25033.5 | 0 | 47550 | 0 %ile | 100 %ile |
biomesight | 93.63 | 210 | 8650 | 1180 | 9010 | 0 | 25912 | 6293.3 | 3550 | 10009.4 | 50 | 10288 | 10.6 %ile | 90.7 %ile |
thryve | 99.28 | 663 | 46004 | 2309 | 33955 | 0 | 76679 | 21357.3 | 12948 | 28225.5 | 0 | 39780 | 10.4 %ile | 90.7 %ile |
ubiome | 95.31 | 507 | 55314 | 1112 | 212711 | 0 | 100909 | 32770.8 | 22395 | 34764.6 | 513 | 63335 | 4.8 %ile | 99.3 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Lab Teletest | 0 | 500 | 0 | 0.05 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 99.86 % | 0.615 % | 1.009 % | 2860.0 | 2864 |
BiomeSightRdp | 28.125 % | 1.721 % | 2.813 % | 9.0 | 32 |
bugspeak | 100 % | 0.079 % | % | 1.0 | 1 |
CerbaLab | 100 % | 4.854 % | 4.469 % | 3.0 | 3 |
CosmosId | 90.625 % | 3.023 % | 2.838 % | 29.0 | 32 |
custom | 23.729 % | 0.678 % | 1.129 % | 14.0 | 59 |
es-xenogene | 3.448 % | 5.768 % | % | 1.0 | 29 |
Medivere | 100 % | 0.382 % | 0.348 % | 7.0 | 7 |
Microba | 75 % | 1.898 % | 1.595 % | 21.0 | 28 |
Microba1 | 100 % | 8.94 % | % | 1.0 | 1 |
SequentiaBiotech | 16.667 % | 1.473 % | 0.8 % | 6.0 | 36 |
Thryve | 99.349 % | 2.281 % | 3.267 % | 1374.0 | 1383 |
uBiome | 94.949 % | 3.269 % | 3.472 % | 752.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.